Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Induction of apoptosis in hepatocellular carcinoma Smmc-7721 cells by vitamin K 2 is associated with p53 and independent of the intrinsic apoptotic pathway

Apoptusis of SMMC-7721 Cells Induced by Vitamin K3 Via Up-Regulating Fus Expression on the Surface of Cells

Effect of vitamin K3 on inducing apoptosis in cell line SMMC-7721 of human liver cancer and expression of survivin gene

Apoptosis of SMMC-7721 cells induced by Vitamin K3 and changes of SOD,GSH and MDA in them

Enhanced therapeutic efficacy of vitamin K2 by silencing BCL-2 expression in SMMC-7721 hepatocellular carcinoma cells.

Inhibitory effects of vitamin K2 on the highlv metastatic cell line MHCC97-H of human hepatocellular carcinoma

Inhibition Effect of Vitamin K2 on K562 Cells Growth

The Study Of Effect And Mechanism By Vitamin K2 On Human Mds Cell Line Mutz-1.

Vitamin K2 Inhibits Hepatocellular Carcinoma Cell Proliferation by Binding to 17β-Hydroxysteroid Dehydrogenase 4

Vitamin K2 Inhibits the Growth of Hepatocellular Carcinoma Via Decrease of Des-Gamma-carboxy Prothrombin.

Inhibition of vitamin C on the proliferation and apoptosis of hepatocellular carcinoma cells SMMC-7721

[Inhibition Effect of Vitamin K2 on Human MDS-JSN04 Cell Line and Its Possible Mechanism].

[Possible Mechanism Underlying Apoptotic Induction Effect of Vitamin K2 on Human MDS Cell Line MUTZ-1].

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

Expressions of Apoptosis-Related Gene Survivin,bcl-2 and Bax in the VK_2-induced Apoptosis of HL-60 Cells

Effect of Vitamin K_(3) on Apoptosis Induced by Androgen - Independent Prostate Cancer Cell PC-3M

Clinical Application of Protein Induced by Vitamin K Antagonist-Ii As a Biomarker in Hepatocellular Carcinoma

Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells

Study of Effect by Vitamin K_2 on Human MDS Cell Line MUTZ-1

Vitamin K2 Downregulates the Expression of Fibroblast Growth Factor Receptor 3 in Human Hepatocellular Carcinoma Cells

Vitamin K4 Inhibits the Proliferation and Induces Apoptosis of U2OS Osteosarcoma Cells Via Mitochondrial Dysfunction.